is X user stats_feed reporting correct numbers her...

Here are a few points for reference:

- Countries like Iceland, Portugal, Canada, Australia, and the USA generally report some of the highest rates of antidepressant use per 1,000 people, often exceeding 100 users per 1,000, which aligns with your numbers (e.g., Iceland at 161, Portugal 139, Canada 130).

- European countries such as Sweden, UK, France, and Germany often have rates ranging from approximately 50 to over 100 per 1,000 population, which matches your data.

- Lower rates in countries like India (9), Latvia (21), and Russia (23) also correspond with known lower consumption rates in those regions, often reflecting differences in healthcare access, stigma, and prescription practices.

- South Korea (27) and Hungary (29) have relatively moderate levels reported in various studies, consistent with your figures.

To verify accuracy, it's recommended to consult the latest OECD Health Statistics antidepressant consumption data or WHO country profiles, as numbers can change over time.

Overall, your list seems to be a reasonable representation of antidepressant user rates per 1,000 people as reported by major organizations.

What seems plausible:
- The broad pattern aligns with known trends - Nordic countries, English-speaking countries, and some Western European nations typically have higher reported antidepressant usage rates
- Iceland, Portugal, and Canada being at the top is consistent with OECD data I've seen
- Lower rates in countries like India and some Eastern European nations could reflect various factors (access, reporting, cultural attitudes toward mental health treatment)

What to consider:
- These statistics can vary significantly depending on:
- Data collection methods and year
- Whether they measure prescriptions vs. actual usage
- Healthcare system differences
- Cultural attitudes toward mental health treatment
- Access to healthcare and psychiatric services

Red flags to watch for:
- Social media "stats" accounts sometimes mix data from different years or sources
- The phrase "according to OECD, WHO, and other local sources" is vague - legitimate statistics usually cite specific reports

My recommendation: If you need these numbers for anything important, I'd suggest checking the original OECD Health Statistics database or WHO reports directly, as they're the most reliable sources for this type of international health data.

General Observations:

* OECD Focus: The OECD does collect and publish data on antidepressant consumption. Their data is generally considered reliable, but focuses on member countries. The inclusion of India, Russia, Costa Rica, and Brazil necessitates checking sources beyond just the OECD.
* Variation in Data Collection: Different countries use different methodologies for collecting data on antidepressant use. This can include prescription rates, sales figures, or survey data. Direct comparisons should be made with caution.
* Time Period: Antidepressant usage can change over time. The accuracy depends on the time period the data represents. A specific year should be provided to ensure accuracy.
* Per 1,000 vs. Per Capita: The phrasing "per 1,000 people" is often used interchangeably with "per capita," but it's important to be precise.

Potential Issues & Areas to Verify:

* India (9): This number seems low compared to some estimates. While antidepressant use is lower in India than in many Western countries, 9 per 1,000 seems exceptionally low considering the prevalence of mental health issues and increasing awareness. Verify the source and methodology used to arrive at this figure. Cultural factors, access to healthcare, and stigma play a significant role.
* Latvia (21) & Lithuania (36): These seem plausible but check against Eurostat data for prescription rates.
* Russia (23): This seems low compared to general mental health estimates, potential access and social stigma for mental health could play a factor.
* Costa Rica (39) & Brazil (58): These require careful sourcing. Check for national health surveys or reports that include antidepressant usage data.
* General Ranking: The relative rankings seem generally plausible (Nordic countries and North America tend to be higher). However, the specific numbers should be verified against multiple sources.
* High End (Iceland 161, Portugal 139, Canada 130, Australia 122, USA 110, UK 108, Sweden 105): These higher numbers are in line with general trends and reported data from OECD and national health agencies, but the specific numbers should be validated.

How to Verify the Data:

1. Identify the Source: Find out the exact source "X user stats_feed" used. Did they cite a specific OECD report, WHO publication, or national health survey?
2. Check OECD Data: Go to the OECD iLibrary and search for data on antidepressant consumption. Compare the numbers to the ones provided. Look for data specifically on "Pharmaceutical Consumption" or "Mental Health."
3. Consult WHO Data: The WHO Mental Health Atlas might contain relevant information, though it might not provide the exact "per 1,000" figures.
4. Search for National Health Statistics: For each country, search for the national health ministry or statistics agency website. Look for reports or surveys on mental health and pharmaceutical usage. Examples:
* USA: CDC (Centers for Disease Control and Prevention), National Center for Health Statistics (NCHS)
* UK: NHS (National Health Service), Office for National Statistics (ONS)
* Canada: Statistics Canada, Health Canada
* Australia: Australian Institute of Health and Welfare (AIHW)
5. Look for Academic Studies: Search Google Scholar for studies on antidepressant use in specific countries. These studies often provide more detailed data and analysis.
6. Consider Methodology: When comparing data, pay attention to the methodology used to collect the data. Are they based on prescriptions, sales, or surveys? What is the age range of the population included in the data?

In Conclusion:

The list provided by "X user stats_feed" gives a general overview, but requires thorough verification before it can be considered definitively accurate. Focus on identifying the source, checking against reputable organizations like the OECD and WHO, and comparing with national health statistics. Be mindful of methodological differences and the time period the data represents. The figure for India seems particularly suspect and warrants extra scrutiny.